Daunorubicin Injection Manufacturer, Exporter & Global Supplier in India

Daunorubicin Injection manufacturer, as a trusted we specialize in producing high-quality formulations that meet stringent international standards, ensuring efficacy, safety, and global availability. Daunorubicin Injection is a vital chemotherapy medicine widely used in oncology practice for the treatment of various blood cancers. Belonging to the anthracycline class of antineoplastic drugs, Daunorubicin works by interfering with the DNA replication process in rapidly growing cancer cells, ultimately leading to cell death.

About Daunorubicin Injection

Daunorubicin is commonly prescribed for acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). It is administered intravenously and often used in combination with other chemotherapeutic agents as part of intensive treatment regimens. Our state-of-the-art production facilities allow us to operate not only as a leading Daunorubicin Injection manufacturer in India but also as a recognized exporter and global supplier serving oncology markets worldwide.

Uses and Benefits

• Acute Myeloid Leukemia (AML): One of the standard drugs in induction therapy.

• Acute Lymphocytic Leukemia (ALL): Often used in pediatric and adult cases alongside other agents.

• Cytotoxic Action: Targets rapidly dividing cells to reduce the leukemia burden.

• Combination Therapy: Enhances treatment response when paired with cytarabine and other chemotherapy drugs.

• Trusted Quality: As a reputed Daunorubicin Injection manufacturer, we provide products that are quality-tested for global healthcare institutions.

Dosage and Administration

Daunorubicin Injection is administered intravenously under medical supervision. Dosage varies based on patient age, body surface area, type of leukemia, and specific treatment protocol. Since this is a high-risk chemotherapy drug, preparation and administration must always be handled by trained oncology healthcare professionals. Our packaging solutions, offered by a WHO-GMP certified Daunorubicin Injection manufacturer, ensure safe handling and transport for hospitals and treatment centers.

Precautions

Being a responsible Daunorubicin Injection manufacturer, we emphasize the following precautions:

• Should only be administered in facilities with expertise in managing cytotoxic chemotherapy.

• Risk of cardiotoxicity; regular heart monitoring is recommended.

• Blood counts must be checked frequently due to the risk of bone marrow suppression.

• Avoid in patients with severe hepatic impairment unless adjusted by the treating physician.

• Pregnant and breastfeeding women should not receive Daunorubicin because of potential risks to the baby.

• Patients must be closely monitored for infections and bleeding complications.

Possible Side Effects

Like many potent anticancer drugs, Daunorubicin may cause certain side effects, including:

• Nausea, vomiting, and diarrhea

• Hair loss (alopecia)

• Red coloration of urine (temporary and harmless)

• Low blood cell counts (neutropenia, thrombocytopenia, anemia)

• Mouth sores or mucositis

• Cardiac issues such as arrhythmias or reduced heart function with prolonged use

Our role as a quality-driven Daunorubicin Injection manufacturer ensures each batch undergoes rigorous testing to minimize adverse events and meet international safety guidelines.

Why Choose Us?

• WHO-GMP and ISO certified Daunorubicin Injection manufacturer in India.

• Recognized exporter and global supplier for oncology formulations.

• Competitive pricing with uncompromised quality.

• Strong distribution networks across Asia, Africa, Middle East, and Latin America.

• Compliance with international pharmacopeia standards.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Daunorubicin Injection to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.